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Background: Kinetic discrimination is essential in antibodyantigen recognition.
Results: An otherwise fast second-order reaction is limited by a slow proline isomerization of the epitope.
Conclusion: The antibody recognizes the less populated isoform, suggesting presentation of the epitope as a non-native conformer.
Significance: The conformational diversity of an intrinsically disordered viral epitope slows down the reaction with the anti-
body without specificity cost.
Conformational rearrangements in antibodyantigen recog-
nition are essential events where kinetic discrimination of iso-
mers expands theuniverse of combinations.We investigated the
interaction mechanism of a monoclonal antibody, M1, raised
against E7 from human papillomavirus, a prototypic viral onco-
protein and a model intrinsically disordered protein. The
mapped 12-amino acid immunodominant epitope lies within a
“hinge” region between the N-terminal intrinsically disordered
and the C-terminal globular domains. Kinetic experiments
show that despite being within an intrinsically disordered
region, the hinge E7 epitope has at least two populations sepa-
rated by a high energy barrier. Nuclear magnetic resonance
traced the origin of this barrier to a very slow (t1⁄24min) trans-
cis prolyl isomerization event involving changes in secondary
structure. The less populated (10%) cis isomer is the binding-
competent species, thus requiring the 90% of molecules in the
trans configuration to isomerize before binding. The associa-
tion rate for the cis isomer approaches 6 107 M1 s1, a ceiling
for antigen-antibody interactions. Mutagenesis experiments
showed that Pro-41 in E7Ep was required for both binding and
isomerization. After a slow postbinding unimolecular rear-
rangement, a consolidated complex with KD  1.2  107 M is
reached. Our results suggest that presentation of this viral
epitope by the antigen-presenting cells would have to be
“locked” in the cis conformation, in opposition to themost pop-
ulated trans isomer, in order to select the specific antibody clone
that goes through affinity and kinetic maturation.
Specific recognition of foreign antigens by antibodies is the
primary event in the immune system’s fight against disease.
Antibodies are at the center of humoral, cellular, and innate
responses. The first molecular understanding of antibody
antigen recognition came from the x-ray structure of antibody
molecules (1). To date, there are nearly 800 antigen-antibody
structures (2), a large body of information from bioinformatics
analyses has been accumulated (3), and a number of general
rules were extracted together with some thermodynamic infor-
mation on binding interfaces (4). It was recognized early that a
large number of antigen-antibody complexes underwent sub-
stantial conformational changes upon formation (5). Notwith-
standing the fact that these structures provide exquisite detail
for those changes, the comparison of structures of liganded and
unliganded antibodies and epitopes cannot discriminate
changes that occur after interaction between the molecules
(induced fit) from those resulting of a preexisting equilibrium
(conformational selection). The discrimination between these
two scenarios from either the antibody or the antigen side is of
utmost importance in immunological terms and requires
detailed kinetic mechanistic investigation.
Conformational heterogeneity in antibodies has long been
known. The idea that antibodies produced by a given B-cell
from a single sequence could present more than one fold or
conformer was first proposed by Pauling in 1940 (6) and later
demonstrated by Foote andMilstein in 1994 (7). Different con-
formations adopted by a single antibody sequence may react
with different antigens, which is the basis for cross-reactivity, a
fundamental phenomenon behind autoimmunity and allergy
(8, 9). In addition, antibody conformational isomerism has
direct implications for antibody diversity and the expansion of
the immune repertoire. James et al. (8, 10) later carried out a
comprehensive and integrative analysis of another antibody-
hapten interaction using the Fv heterodimer SPE7 IgE model.
Crystallographic and pre-steady-state kinetic analyses showed
that the antibody adopted at least two different conformations
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(8, 10). Antigen recognition starts by selection of one of these
conformers, and this first complex subsequently undergoes an
induced fit conformational transition (8, 10).
Multiple conformations and conformational selection events
on the antigen side have also been reported. In a leucine zipper
model, the antibody selected a pre-existing monomeric con-
former and shifted the equilibrium from a native coiled-coil to
a monomeric, unfolded species (11, 12). A somehow different
example comes from an epitopewithin the folded dimeric tran-
scriptional regulator E2 fromhuman papillomavirus (HPV).5 In
this case, the rate constant for antibody association was rather
slow (104 M1 s1), indicative of a conformational rearrange-
ment of the antigen as the rate-limiting step (13).
Peptide epitopes are mostly unstructured but show confor-
mational tendencies in solution, and a correlation between
these structural tendencies and antigenicity was observed (14).
In the absence of stable structure, Xaa-Pro peptide bonds can
populate both the cis and trans isomers to measurable degrees.
Cis-trans isomerization thus provides a molecular switch that
works in the minute time scale and can expand the conforma-
tional repertoire of proteins. Recent evidence shows that pro-
line isomerization in both disordered and globular domains can
regulate the kinetics of processes such as phage infection (15),
antibody folding (16), estrogen receptor signaling (17), self-in-
hibition of a signaling protein (18), and aggregation dynamics of
the intrinsically disordered Tau protein (19). It has been pro-
posed that some antibodies do recognize the less populated cis
isomer of the peptide bond (20, 21). However, in many of these
cases, the evidence is indirect, and in none of them was the
kinetic mechanism of recognition addressed.
The HPV E7 oncoprotein is the main transforming factor of
this pathogen, involved in many types of neoplasias, cervical
cancer being themost significant (see Ref. 22 for a review). E7 is
also a tumor virus-transforming protein and a model protein
targeting the retinoblastoma tumor suppressor and cell cycle
regulator (Rb). By targeting Rb for proteasomal degradation, E7
causes the release of the transcription factor E2F and forces the
cells into S phase in order to use the cell machinery for DNA
replication and further transcription of other early and late
genes required for the completion of the virus life cycle (23).
From the immunological point of view and as the major trans-
forming protein, E7 is constitutively expressed at high levels in
carcinoma tissues, and antibodies are found in sera at higher
frequency in patients with cervical cancer (24). Thus, E7 and
derivatives are being exploited both in diagnostics and thera-
peutic vaccination (25, 26).
E7 also emerges as a paradigmatic example of an intrinsically
disordered protein (IDP) (27). IDPs are fully functional, most
often “promiscuous binders” related to cell signaling pathways
(28, 29), characterized by extended conformations without
canonical secondary structure and by the lack of tertiary struc-
ture. IDPs are enriched in particular among viral proteins,
which are oftenmultifunctional, because viruses are required to
have a minimal amount of genes (30). HPV16 E7 was shown to
be an extended, non-globular protein (31), characterized by an
intrinsically disordered nature that maps to its N-terminal
domain (E7N) (32) and by a globular C-terminal domain (Fig. 1,
A andC). E7N contains several linearmotifs that mediate bind-
ing to different ligands (33). The E7 protein can also form olig-
omers with chaperone activity that are present in HPV-trans-
formed cells and cancerous tissues (34, 35).
In this work, we present a detailed mechanistic study of the
interaction between an immunodominant peptide epitope of
HPV-16 E7 (36, 37) and themonoclonal antibodyM1, raised by
immunizationwith the full-length E7 protein (34). The reaction
was dissected into a very slow pre-equilibrium isomerization
followed by a fast association reaction and, finally, by a unimo-
lecular rearrangement. Kinetic association experiments and
nuclear magnetic resonance measurements of the free epitope
showed that the antibody specifically recognizes a cis proline
isomer in the interdomain “hinge” region of E7. Thus, by mak-
ing use of an important viral disease and cancer-related antigen,
we reveal that binding of an epitope within an intrinsically dis-
ordered protein may depend on a slow proline isomerization
process.
EXPERIMENTAL PROCEDURES
Proteins and Peptides—M1 IgGwas purified from ascitic flu-
ids, and the derived Fab fragments were prepared following
standard procedures with minor modifications. Briefly, after
clarification of ascitic fluids, the sample was exchanged into
formate buffer and loaded onto a high performance cationic
exchange ceramic S-HyperD column (Pall Corp.). The desired
fractions were pooled, exchanged into TBS buffer, and concen-
trated. Fab fragmentswere prepared by papain hydrolysis of the
IgG molecules and purified by ionic exchange in a Q-HyperD
column (Pall Corp.). M1 Fab purity was 95% as judged by
SDS-PAGE. RecombinantHPV16 andHPV18 E7 proteins were
expressed and purified as described previously (31, 38).
Synthetic peptides corresponding to the N terminus of
HPV16 E7 and proline mutants were obtained from the Keck
facility (Yale University, New Haven, CT), purified by reverse
phase HPLC, and submitted to mass spectrometry. The pep-
tides were quantified by tyrosine absorption at 273 nm in 0.1 M
NaOH and UV absorption at 220 nm in HCl for the peptides
without tyrosine. The different E7 synthetic peptides used in
this study are shown in Fig. 1A.
Fluorescein Isothiocyanate (FITC) Labeling—HPV16 E7 and
synthetic peptides were labeledwith FITC (Sigma catalogue no.
F-3651). The coupling reaction was conducted as described
previously (39).
ELISAs—The epitope mapping was measured by a conven-
tional ELISA. Briefly, 96-well plates (Greiner bio-one, high
binding)were sensitized overnight at 4 °Cwith 0.5g/well of E7
andE7C-terminal domain (E7(40–98)) proteins or 1g/well of
the different E7 fragments in Tris-buffered saline (25 mM Tris-
HCl and 600 mM NaCl, pH 7.4). The ionic force of the buffer
was set to 0.6 M NaCl. After blocking with 1% bovine serum
albumin (BSA) (BSA/TBS), ascitic fluids and control serum
samples were diluted in BSA/TBS, and their reactivity was
revealed by incubation with peroxidase-conjugated polyclonal
antibodies to murine IgG (Jackson). The final color was read at
492 nm in an ELISA reader (SLT Spectra).
5 The abbreviations used are: HPV, human papillomavirus; IDP, intrinsically
disordered protein.
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Equilibrium Binding—Measurements were performed in an
Aminco-Bowman Series 2 spectrofluorimeter assembled in L
geometry. A fixed amount of FITC-E7 protein was incubated
with increasing concentrations of M1 in different tubes for 30
min prior to fluorescence measurements. A similar protocol
was used to titrate FITC-E7(36–48), FITC-E7(36–53), and
FITC-E7(36–48) proline mutant peptides with M1Fab. The
dissociation constant (KD) of the complex was calculated by
fitting the plot of observed fluorescence anisotropy (r) change
of FITC-E7 or FITC-E7 peptides versus different M1 concen-
trations to the following equation assuming a 1:1 stoichiometry
(40),
r  rfree
rint
2
(x E7] KD x E7] KD
2
 4E7]x0.5 (Eq. 1)
where x represents the variable total concentration of M1Fab,
rint is the difference in intrinsic fluorescence anisotropy
between the free and complexed fragments, and rfree is the
fluorescence anisotropy of the free fragment.
Association and Dissociation Kinetics—Fluorescence stopped-
flow kinetic experiments were performed using an SX.18MV
stopped-flow apparatus (Applied Photophysics, Leatherhead,
UK). All reported concentrations are those resulting frommix-
ing equal volumes of each syringe. The association and dissoci-
ation reactions were monitored by following the change in
fluorescence intensity or fluorescence anisotropy of the FITC-
E7Ep peptide. For fluorescence measurements, the excitation
monochromator was set to 495 nm with a 4.6-nm band pass,
and emission was collected through a 515-nm cut-off filter
(Schott, Duryea, PA). For anisotropy measurements, two pho-
tomultiplier tube detectors were assembled in T-geometry, and
vertically and horizontally polarized emissions were collected
through 530-nm cut-off filters.
The bimolecular association reaction was measured under
second-order conditions by mixing equimolar amounts of
M1Fab and FITC-E7Ep. Under these conditions, the data can
be analyzed by the following second-order equation (41),
Ft  Fo  FM1Fab]0
2kont1 M1Fab]0kont c1t
(Eq. 2)
where F represents the fluorescence at time t, F is the change
in fluorescence upon binding, Fo is the fluorescence at t  0,
[M1Fab]o is the initial concentration of M1Fab, and kon is the
second-order rate constant. Signal drift was taken into account
by a linear time-dependent term (c1).
Dissociation traces were measured by displacing a stoichio-
metric FITC-E7EpM1Fab complex by adding a 20-fold excess
of unlabeled E7Ep peptide. The traces were fit to the sumof two
exponential functions to obtain the koff values,
Ft  Fo  A1  e
k1t  A2  e
k2t (Eq. 3)
where A1 and A2 are the amplitudes, Fo is the initial fluores-
cence value, and k1 and k2 are the dissociation rate constants for
each phase.
Concentration Dependence—Slow association phases were
measured bymanual mixing using a fluorimeter. The change in
anisotropy was measured after the addition of increasing con-
centrations ofM1Fab to a cuvette containing 50 nM FITC-E7Ep
or 50 nM FITC-P47A E7Ep. The individual data traces were fit
to a single exponential function to obtain the observed rate
constant for the reaction (supplemental Tables S1 and S6). The
dependence of the observed rate constant on M1Fab concen-
tration was fit to a previously described pre-equilibriummodel
(10),
kobs k1 k1  KD2M1Fab] KD2 (Eq. 4)
where kobs is the observed association rate constant at each
M1Fab concentration, k1 and k1 are the forward and reverse
rate constants for the pre-equilibrium reaction, and KD2 is the
dissociation equilibrium constant for the bimolecular associa-
tion reaction. The concentrations used yielded errors in free
M1Fab concentration of less than 20 and 5% for the lowest and
highest M1Fab concentrations tested, respectively (100 nM and
1 M), allowing a reliable estimation of the fitting parameters.
Using these parameters, we obtained the equilibrium associa-
tion constants for the pre-equilibrium and association reac-
tions: K1 k1/k1 and K2 1/KD2, respectively. From this, it is
possible to calculate the global equilibrium dissociation con-
stant KD(global) (1	 K1)/(K1
 K2). Finally, using the equi-
librium dissociation constant for the bimolecular association
reaction (KD2) and the association rate constant obtained in the
second order stopped-flow experiments (k2), one can calculate
the dissociation rate constant for the bimolecular association
reaction as k2 KD2
 k2.
We considered the existence of a second unimolecular reac-
tion with an equilibrium association constant K3, correspond-
ing to rearrangement of the complex. The value of K3 can be
estimated from the equilibrium dissociation constant KD, the
equilibriumconstant for the preassociation equilibriumK1, and
the dissociation constant for the bimolecular association reac-
tion K2 and the following relationship (42).
KD 
1  K1
K1  K2  K1  K2  K3
(Eq. 5)
Temperature Dependence—The slow association phase was
measured at different temperatures in the same conditions
described for the concentration dependence experiments. The
change in anisotropywasmeasured after the addition of 600 nM
M1Fab to a cuvette containing 100 nM FITC-E7Ep. The indi-
vidual traces were fit to a single exponential function to obtain
the observed rate constant for the reaction (supplemental Table
S2). Activation parameters were determined from the Eyring
plot of ln(k (h/k*T)) versus 1/T, where h is the Planck constant,
k* is the Boltzman constant, T is expressed in Kelvin, and k
corresponds to the observed rate constants determined at the
different temperatures. The enthalpy of activation was
obtained from the slope H‡/R of this plot, where R is the
universal gas constant.
Circular Dichroism—Far-UV CD measurements were con-
ducted on a Jasco J-810 spectropolarimeter using a Peltier tem-
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perature-controlled sample holder and a 0.1-cm path length
cell. All measurements were carried out in 10mMTris-HCl (pH
7.4) and 5 mM NaCl at 20  0.1 °C. For the association kinetic
experiment, the ellipticity change at 203 nmwasmeasured after
mixing equal amounts of E7Ep andM1Fab (5 M). Traces were
fit to single exponential functions to obtain the kobs values.
DataAnalysis and Fitting—Fitting of the datawas carried out
using the software programsProfit (Quantumsoft) andKaleida-
graph version 4.0 (Synergy Software) to obtain parameters and
their S.D. values.
NMR Spectroscopy—NMR experiments were carried out at
600.13 MHz on a Bruker Avance 600-MHz spectrometer
equipped with an UltraShield Plus magnet and a triple reso-
nance cryoprobe with gradient unit. The NMR data were pro-
cessed on Linux workstations with NMRView/NMRPipe soft-
ware (43, 44). The NMR samples contained 3mM E7Ep peptide
dissolved in water, pH 7.5 (10 or 100% D2O (v/v)). Proton and
carbon chemical shift assignments were achieved by analyzing
the following experiments at natural abundance: 1H-13C
HMQC, 1H-13C HMQC-TOCSY (70-ms mixing time), 1H-1H
TOCSY (70-msmixing time), and 1H-1HNOESY (250-msmix-
ing time). A series of NOESY experiments of the E7Ep peptide
with variable mixing times (0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.8, 1, and
1.2 s) were performed at 30 °C to obtain the kinetic rates of the
proline cis-trans isomerization. At 40 °C, 0.15-, 0.3-, 0.5-, 0.7-,
and 0.9-s mixing times were used. The spectra were acquired
with 8K*800 complex data points in the t1
 t2 dimensions and
with 24 scans. A 1H-13C HMQC spectrum was performed at
each temperature to follow the chemical shift changes with
temperature. In theNOESY spectrum, the intensity of the diag-
onal peaks and of the chemical exchange cross-peaks are
related to the mixing time, m, by the following equations,
Idiag(m) cosh(km)e
k  T1
 1m (Eq. 6)
Icross(m) sinh(ktm)e
k T1
1m (Eq. 7)
where cosh and sinh are the hyperbolic cosine and sine, respec-
tively, k is the kinetic rate for the chemical exchange process,
and T1 is the spin-lattice relaxation time of the relevant pro-
tons. Assuming that the T1 relaxation rates are the same for the
respective protons in the cis and trans isomerizations, we
obtain the following.
Icross
Idiag
(m)
sinh(km)
cosh(km)
 tanh(km) (Eq. 8)
For short mixing times, Equation 8 simplifies to the following.
Icross
Idiag
(m) km (Eq. 9)
Equation 9 was used for the analysis of the kinetics of the cis-
trans proline interconversion. Exchange rate constants were
obtained by fitting the diagonal and cross-peaks intensities of 
protons of prolines. The thermodynamic equilibrium cis-trans
isomerization constants were also obtained from themole frac-
tions xcis and xtrans, which were calculated by integrating the
volumes of the cross-peaks corresponding to cis and trans pro-
line isomers at each temperature in the a 1H-13C HMQC
spectrum.
RESULTS
M1 Monoclonal Antibody Epitope Mapping and Affinity
Determination—Papillomavirus E7 proteins show a high
degree of sequence conservation across over 200 different virus
types (45). The two most clinically relevant types infecting
humans are HPV16 and HPV18, which account for over 70% of
cervical cancers.We have previously reported the generation of
a monoclonal antibody, M1, raised against HPV16 E7 (34). IgG
M1 presents a very high reactivity towardHPV16 E7 (1:120,000
titer) and a low reactivity toward HPV18 E7 (1:250 titer), which
yields a 500-fold discrimination factor (supplemental Fig. S1).
In order to map the epitope within E7, we analyzed IgG M1
recognition of different fragments encompassing various
regions of the HPV16 E7 protein (Fig. 1A) by standard ELISAs.
We found no reactivity for either the complete E7 N-terminal
(E7(1–40)) or C-terminal (E7(40–98)) domains or for the frag-
ments E7(1–20) and E7(16–40) spanning the conserved
regions CR1 and CR2 from the N-terminal domain (Fig. 1B).
This result suggested that the epitope spans sequences belong-
ing to both domains. In fact, IgG M1 presented the highest
reactivity for the full-length E7 protein but an almost identical
reactivity for fragment E7(36–53), which lies in the linker
region connecting both domains (Fig. 1, B and C), and a signif-
icant reactivity for the smaller fragment E7(36–48) (Fig. 1B).
ELISA is an effective method for reactivity screening and
epitope mapping but does not provide accurate quantitative
measurements of affinities in solution. Therefore, we decided
to test the affinity of theM1-E7 interaction using an alternative
technique that could overcome these limitations.Wemade use
of fluorescence spectroscopy by performing titration experi-
ments using FITC-labeled E7 species and the Fab fragment of
M1 antibody (M1Fab). By measuring fluorescence anisotropy
changes in titrations performed at high (1 M) protein concen-
tration, we found thatM1Fab bound to full-length E7with a 1:1
stoichiometry (Fig. 2A, inset), expressed as one monomer of E7
per monomer of M1Fab. A titration experiment for the
E7-M1Fab interaction under dissociating conditions yielded a
KD of 20 3 nM (Fig. 2A). A similar experiment yielded a KD of
122  2 and 129  2 nM for the E7(36–53) and E7(36–48)
fragments, respectively (Fig. 2B). Although there was a 6-fold
difference in affinity between the E7 fragments and full-length
E7, these results indicated that the affinities of the two frag-
ments tested were similar and that the E7(36–48) constituted
the minimal binding epitope, which we named E7Ep.
Dissociation Kinetics of the M1FabE7Ep Complex—Anti-
body affinity maturation is based on the modification of the
relative association and dissociation rates of antibodyantigen
complexes (46). Therefore, as an essential part of elucidating
the M1Fab-E7Ep interaction mechanism, we addressed the
kinetics of dissociation and association. Full-length E7 gave
poor anisotropy and fluorescence signal changes upon M1Fab
binding, precluding kinetic analyses (not shown). This was
probably because the fluorescent label was coupled at the
intrinsically disordered N terminus, 30 residues away from
the binding epitope.We thus focused our kinetic studies on the
Antibody Recognition of an Intrinsically Disordered Epitope
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minimal E7Ep epitope using FITC-E7Ep, which reported larger
fluorescence changes upon binding.
We first tackled the dissociation kinetics by forming a stoi-
chiometric FITC-E7EpM1Fab complex. Once stabilized, we
displaced FITC-E7Ep with a 20-fold excess of unlabeled pep-
tide. We monitored the time course of the change in fluores-
cence anisotropy in a stopped-flow apparatus and observed that
two exponential phases were required to explain the shape of
the anisotropy signal decrease. This was indicative of at least
two reactions in the dissociation process (Fig. 3). The two
observed kinetic dissociation rate constants were koff1 0.63
0.05 s1 and koff2  0.026  0.001 s1. Similar values were
obtained by fits of the change in fluorescence intensity (koff1
0.56 0.02 s1 and koff2 0.015 0.001 s1, supplemental Fig.
S2). The final anisotropy value in the stopped-flow experi-
ments (r  0.03; Fig. 3) was in excellent agreement with the
initial anisotropy value from the equilibrium titration exper-
iments (r  0.033; Fig. 2B), indicating that complete disso-
ciation of the FITC-E7EpM1Fab complex had taken place.
The relative amplitudes obtained from the anisotropy
change were 90% for the faster and 10% for the slower
phases, respectively (Fig. 3).
AssociationKinetics of the E7EpM1FabComplex Followed by
Fluorescence—We monitored the association kinetics in
stopped-flow experiments by following the fluorescence inten-
sity signal change after mixing equimolar amounts of FITC-
E7Ep andM1Fab at 50, 200, and 430 nM (Fig. 4A). The reaction
showed clear concentration dependence and proceeded faster
at higher protein concentrations, in accordance with a bimo-
lecular association. The data were fitted to a second-order
FIGURE 1.Mappingof theM1 recognition site.A, amino acid sequence of theHPV16 E7protein. The location of the E7N-terminal (E7N) and the E7C-terminal
(E7C) domains (solid line), the linker region (dashed line), and the conserved regions CR1 and CR2 are shown above the sequence. Conserved proline residues
in the linker region are shown in boldface type. The E7 fragments used in this study are shown below the sequence, with the amino acids spanned by each
fragment shown in parenthesis. B, M1 IgG reactivity against different HPV16 E7 fragments assayed by indirect ELISA. E7, full-length E7 protein (amino acids
1–98). Peptides from different regions of the protein are indicated. Control, non-related E2 peptide. Black bars, M1-purified IgG.White bars, non-related IgG.
C, schematic representation of the HPV E7 dimer (Protein Data Bank entry 2F8B) and its E7N and E7C domains. Monomers are depicted in violet, and the M1
epitope (E7Ep) is shown in red. Orange spheres, zinc atoms.
FIGURE 2. Equilibrium dissociation of M1Fabantigen complexes. A, FITC fluorescence anisotropy changemeasured upon adding increasing amounts of
M1Fab to a cuvette containing 50 nM FITC-E7protein. Inset, equilibrium titration performed at 1M FITC-E7, showing a 1:1 FITC-E7M1Fab binding stoichiom-
etry.B, FITC fluorescence anisotropy changemeasureduponadding increasingamounts ofM1Fab to a cuvette containing100nMFITC-E7(36–48) (open circles)
or 100 nM FITC-E7(36–53) (filled circles) peptides. The differentM1Fabantigen complexes were incubated in separate tubes for 30min prior tomeasurements.
Lines are fits of the data to a 1:1 binding model, from which the following KD values were obtained for each complex (see “Experimental Procedures”). For
FITC-E7M1Fab, KD 20 3 nM; for FITC-E7(36–48)M1Fab, KD 122 2 nM; for FITC-E7(36–53)M1Fab, KD 129 2 nM.
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model to obtain the kon values. Similar kon values were obtained
at the different protein concentrations tested, with an average
value of kon 6.4 1.8
 107 M1 s1 (Fig. 4A).
Interestingly, a slower process was observed for the associa-
tion reaction measured at 50 nM M1Fab concentration, where
the time base was 5 s. This process could be accounted for by
adding an exponential phase to the model (Fig. 4A). This indi-
cated the presence of a slower process in the association reac-
tion. In order to characterize this phase, we carried out associ-
ation experiments in the fluorimeter by handmixing.We added
increasing concentrations of M1Fab to a cuvette containing 50
nM FITC-E7Ep and measured changes in fluorescence anisot-
ropy. We observed a slow increase in the fluorescence anisot-
ropy signal after adding M1Fab and therefore monitored reac-
tions for about 30 min until an equilibrium value was reached
(Fig. 4B). For all concentrations tested, the increase in anisot-
ropy was well described by a single exponential function (sup-
plemental Fig. S3). The average anisotropy value extrapolated
to t 0 from the fits of the data to a single exponential function
was r  0.039 (supplemental Table S1). Because the average
anisotropy value of the free E7Ep fragment was r 0.031 (sup-
plemental Table S1), we assign the remaining change in anisot-
ropyr 0.008 (supplemental Table S1) to the bimolecular asso-
ciation reaction. The relative amplitude of the slow association
phase increased with increasing M1Fab concentration, and for 1
M M1Fab, 83% of the total anisotropy change corresponded to
the slow association phase, and 17% corresponded to the fast
bimolecular association phase (supplemental Table S1).
The presence of an exponential process in an association
reaction can be due to either postbinding events or to pre-equi-
FIGURE 3. Dissociation kinetics of E7EpM1Fab complex. FITC fluorescence
anisotropy time trace measured upon the addition of a 20-fold excess of unla-
beled E7Ep peptide (E7(36–48)) to a preformed stoichiometric 400 nM FITC-
E7EpM1Fab complex. Full line, fit of the time trace to a double exponential func-
tion. The residuals from fits to a single (top) and double (bottom) exponential
functionareshownbelow thegraph.Thefittedrateconstantswerekoff,10.63
5.2
 102 s1 and koff,2 2.62 0.1
 10
2 s1, and the corresponding ampli-
tudeswere Amp1 1.8 0.2
 10
2 and Amp2 3.5 0.1
 10
3.
FIGURE4.Associationkineticsof theE7EpM1Fabcomplex.A, bimolecular associationphase. FITC fluorescence intensity changeaftermixingFITC-E7Epand
M1Fab at equimolar concentrations. Light gray, 430 nM; dark gray, 200 nM; black, 50 nM. The fits to a second-order association model for each trace were used
to obtain the value of kon for each condition and are shown as full lines (see Equation 2). Residuals from the fits are shown below the graph (430 nM (top), 200
nM (middle), and 50 nM (bottom)). The value obtained by averaging all measurements was kon 6.4 1.8
 10
7
M
1 s1. B, slow association phase. Change in
FITC fluorescence intensitywasmeasured aftermixing 100 nM FITC-E7Epwith 600 nMM1Fab. The addition ofM1Fab antibody (black arrow) was established as
time 0. Traces were fit to a single exponential function to obtain the observed rate constants at each concentration (supplemental Fig. S3). C, concentration
dependence of the slow association phase. The observed rate constants were measured at 50 nM E7Ep and increasing M1Fab concentrations. The data were
fitted to a pre-equilibriummodel by using Equation 4.
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librium conformational rearrangements. The concentration
dependence of the slow association phase can discriminate
between these two scenarios. In our case, the observed rate
constant showed a marked decrease upon increasing M1Fab
concentration (Fig. 4C and supplemental Table S1), which was
indicative of the existence of a pre-equilibrium reaction (8, 47).
The pre-equilibriummodel depicted in Scheme 1 and Eq. 4 was
used to analyze the data and to obtain the microscopic con-
stants for each step. By using this model, we were able to obtain
values for the microscopic rate constants corresponding to the
pre-equilibrium reaction (k1  3.2  0.3 
 103 s1, k1 
2.0  0.3 
 102 s1, K1  k1/k1  1.64  0.18 
 101;
Scheme 1). Moreover, the fit of the data also yields a value for
the equilibrium constant of the bimolecular association reac-
tion (KD2  1.2  0.3 
 107 M; Scheme 1). Finally, using the
value of 6.4 1.8
 107 M1 s1 for the bimolecular association
rate constant obtained by stopped-flowmeasurements (Fig. 4A)
and the equilibrium constant KD2 for the binding reaction esti-
mated from the fit to the pre-equilibrium model, we estimated
the dissociation rate constant for the bimolecular association
reaction (k2 7.5 2 s1; Scheme 1). Using the fitted param-
eters, we calculated the global equilibriumconstant for the two-
step pre-equilibrium model, KD(global)  8.3 
 107 M (see
“Experimental Procedures” and Scheme 1). This value was
6-fold higher than the KD value determined independently in
the equilibrium titration experiments,KD 1.29
 107 M (Fig.
2). This discrepancy suggested the presence of an additional
reaction involving a rearrangement of the E7EpM1Fab com-
plex, which we accounted for in the right-hand side of Scheme
1. From the equilibrium KD value, the pre-equilibrium associa-
tion constant K1, and the bimolecular association equilibrium
constantK2, we estimated an equilibriumconstant for this reac-
tion,K3, of 6 1.5 (see “Experimental Procedures” and Scheme
1). The measured dissociation kinetics also lent support to the
three-step model. On one hand, the slowest dissociation phase
(0.026 s1) was in excellent agreement with the k1 value from
Scheme 1 (0.020 s1). On the other hand, the faster dissociation
phase (0.63 s1) agreed reasonably well with the model from
Scheme 1, because it would be expected to correspond roughly
to the product of k2 times the fraction of E7EpM1Fab inter-
mediate (k2 
 1/K3) if the last equilibrium in the reaction is
fast, which yields a value of 1.25 0.46 s1.
Temperature Dependence of the Pre-equilibrium Association
Phase—The values of the pre-equilibrium kinetic rate con-
stantswere indicative of a slowprocess and could correspond to
the isomerization of a Xaa-Pro peptide bond in either of the
reactants. Inspection of the E7Ep sequence revealed the pres-
ence of two proline residues (Fig. 1A). Protein conformational
changes limited by Xaa-Pro peptide bond isomerization often
present characteristic temperature dependence, with an activa-
tion enthalpy close to22 kcal/mol and a negligible activation
change in heat capacity.We analyzed the temperature depend-
ence of the slow phase by measuring the anisotropy change
after mixing 600 nM M1Fab with 100 nM of E7Ep at different
temperatures. All traces could be fitted to a single exponential
function (supplemental Fig. S4), and as expected, the observed
rate constant became faster as temperature was increased (sup-
plemental Table S2). We estimated the activation parameters
for the reaction from a Eyring plot of the data (ln(k(h/k*T))
versus 1/T), which showed a linear relationship, as expected for
a reaction without a change in heat capacity (Fig. 5A). The acti-
vation enthalpy was H‡24.2 0.68 kcal/mol. The linear-
ity and the H‡ value obtained was characteristic of prolyl
isomerization reactions in peptides (48). This result suggested
that the pre-equilibrium reaction could be limited by a prolyl
isomerization event within E7Ep.
Prolyl Isomerization in E7Ep Determined from NMR—In
order to analyze whether one or both of the Pro residues in
E7Ep presented an isomerization equilibrium in the free form
SCHEME 1.Minimal model for the E7-M1Fab interaction.
FIGURE 5. Temperature dependence of the slow association phase.
A, Eyring plot of the slow association phase, which wasmeasured at different
temperatures bymixing 100nMFITC-E7Epwith 600nMM1Fab. Traceswere fit
to a single exponential function toobtain theobserved rate constants at each
temperature (supplemental Fig. S4). Data were fit to a linear function from
which the enthalpy of activation could be estimated (see “Experimental Pro-
cedures”). The value obtained was H‡24.2 0.7 kcal/mol. B, sequence
logo of the E7Ep region for all E7 proteins from the9 papillomavirus species
(type HPV16, -31, -33, -35, -35H, -52, -58, or -67). The numbering corresponds
to the HPV16 E7 protein. Conserved proline residues are highlighted in black.
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of the peptide, we conducted NMR experiments. Proton and
carbon chemical shift resonances of the E7Ep peptide epitope
were completely assigned using two-dimensional NMR exper-
iments (supplemental Tables S3 and S4). The spectra revealed
two sets of signals originating from Gly-40 to Gln-44 and from
Glu-46 to Asp-48 in the sequence. The fact that residues show-
ing the largest shift differences were either Pro or those adja-
cent to Pro indicated that the weaker set of signals arose from
the cis isomers of Pro residues. Both Pro-41 and Pro-47 were
involved in such exchange process. Cis and trans prolines were
identified from the 13C	 and 13C
 chemical shifts, which differ
significantly in both configurations. 13C	 and 13C
 chemical
shifts for the cis isomer were found to be at 34.4 and 24.6 ppm,
respectively, for Pro-41 and at 34.0 and 24.2 ppm, respectively,
for Pro-47. For the trans isomer, the chemical shifts exhibited
by the same nuclei were 31.9 and 26.9 ppm, respectively, for
Pro-41 and 31.8 and 27.0 ppm, respectively, for Pro-47 (49) (Fig.
6A and supplemental Tables S3 and S4). Also, in the NOESY
spectrum, typical strongH-Hi 1 andH-HNi 1NOEswere
observed for the trans prolines and strong H-Hi 1 and
H-HNi 1NOEs for the cis ones (Fig. 6B). Themole fraction of
the cis and trans isomers, xcis and xtrans, were obtained by inte-
grating the volumes of the cross-peaks corresponding to cis and
trans proline isomers at each temperature in the 1H-13C
HMQC spectrum. For both proline residues in the peptide, the
trans isomer was the most populated, with the cis isomer mole
fraction, xcis, being 0.152 0.020 and 0.049 0.005 for Pro-41
and Pro-47, respectively, at 30 °C.
Conformational exchange rates were determined from the
NOESY spectra at different mixing times (Fig. 7A). As at 20 °C,
no exchange cross-peaks were observed, and the kinetic rate
constants for the isomerization process were determined at 30
and 40 °C (supplemental Table S5). Selected regions of the
NOESY spectra at different mixing times illustrating the
build-up and decay of the H exchange cross-peaks are shown
in Fig. 7B. The mixing time dependences of the diagonal and
cross-peak intensities show that the diagonal peaks decay expo-
nentially, whereas the chemical exchange cross-peak has a
rapid build-up phase and a competing decay arising from relax-
ation (Fig. 7B). Reasonably good fits were obtained by graphing
the ratios as a function of m) (Fig. 7B), from which the kinetic
rate constants were estimated (supplemental Table S5). The
FIGURE 6. E7Ep peptide proline chemical shift assignment. A, selected region of the 1H-13C HMQC spectrum showing the chemical shift assignment of CH2
groups of positions 	 (left) and 
 (right) of prolines at 20 °C. For both Pro-41 (P41) and Pro-47 (P47), the trans isomer is muchmore abundant at equilibrium (85
and 95%, respectively). B, selected region of the NOESY spectrum at 20 °C showing the cis and trans chemical shift assignments. Characteristic H-Hi 1 NOEs
are observed for the trans prolines, whereas H-Hi 1 cross-peaks are detected in the cis isomers.
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rate constants for the trans to cis isomerizationwere 0.0023 s1
(Pro-41) and 0.0015 s1 (Pro-47), whereas the rate constants
for the cis to trans isomerization were 0.029 s1 (Pro-41) and
0.042 s1 (Pro-47) (Table 1). In addition, equilibrium constants
for the cis-trans proline interconversion obtained from the
ratio between the kinetic forward and reverse rate constants
agreed rather well with those obtained from integrating the
volume of the signals of both isomers in the 1H-13C HMQC
spectrum (supplemental Table S5). Finally, we calculated the
enthalpy of activation for the isomerization reactions from the
measurements at 30 and 40 °C. The H‡ values for the trans to
cis isomerizationwere 20.9 kcal/mol (Pro-41) and 20.8 kcal/mol
(Pro-47), whereas the H‡ values for the cis to trans isomeriza-
tion were 16.6 kcal/mol (Pro-41) and 15.1 kcal/mol (Pro-47)
(Table 1).
The Pre-equilibrium Association Phase Is Limited by trans to
cis Prolyl Isomerization in E7Ep—The NMR experiments
revealed that both proline residues within E7Ep presented a
isomerization equilibrium between cis and trans configura-
tions. We compared the equilibrium and kinetics of the pre-
equilibriumassociation phasewith the equilibriumand kinetics
of prolyl isomerization. The equilibrium constants for the
isomerizations in the peptide and for the pre-equilibrium reac-
tion preceding complex formationwere in agreement (Table 1).
For both prolines, the trans conformer was populated to about
90%, compared with 10% of the cis conformer (Table 1). In the
case of the pre-equilibrium, the value of K1 indicated that 86%
of the molecules must isomerize prior to binding (Table 1).
Additionally, the anisotropy amplitudes of the association
phases indicated that the forward reaction of the pre-equilib-
rium was rate-limiting for 83% of the molecules (Fig. 4B, sup-
plemental Table S1, and Table 1). We concluded that the pre-
equilibrium reaction corresponded to the cis-trans isomeriza-
tion of either Pro-41 or Pro-47.
The kinetic rate constants supported and further clarified
this view. The forward rate constant for the pre-equilibrium
association phase was 0.003 s1, with a H‡ of 24 kcal/mol.
These values were in excellent agreement with the rate con-
stants for trans to cis isomerization of both Pro-41 and Pro-47
at 0.002 s1 and the activation enthalpies of 21 kcal/mol (Table
1). We propose that the forward reaction for the pre-equilib-
rium association is limited by trans to cis isomerization of
Pro-41 or Pro-47. In turn, the reverse process of the pre-equi-
librium association phase had a rate constant of 0.02 s1, in
agreement with the rate constants for cis to trans isomerization
of both Pro-41 and Pro-47 at 0.03 and 0.04 s1, respectively
(Table 1). We thus assigned the reverse reaction for the pre-
equilibrium association to the cis to trans isomerization of
Pro-41 or Pro-47. Altogether, these results strongly suggested
that the fast binding event corresponded to the association
between M1Fab and the E7Ep cis configuration of Pro-41 or
Pro-47, and the slower binding event corresponded to the asso-
ciation of the remaining E7Ep molecules, which was limited by
trans to cis isomerization of Pro-41 or Pro-47.
E7Ep Mutants Identify the Proline Residue Involved in Bind-
ing and Isomerization—In order to confirm whether one or
both E7Ep proline residues were involved in the M1Fab inter-
action, we first performed equilibrium binding experiments
using FITC-labeled E7Ep mutants P41A, P47A, and the P41A/
P47A double mutant. The P47A mutant bound to the M1Fab
FIGURE 7. Prolyl cis-trans isomerization kinetics estimated by NMR. A, selected region of the NOESY spectra at 30 °C recorded with different mixing times
(m) illustrating the variation of the chemical exchange cross-peak intensities for H of Pro-47 (left panels) and Pro-41 (right panels). The exchange cross-peaks are
boxed. B, examples of chemical exchange cross-peak intensity (left) and of diagonal cross-peak intensity (middle) as a function of mixing time. The right panel
shows an example of the cross-peak to diagonal peak intensity ratio. The data were fit to Equation 9 to estimate the kinetic rates for proline isomerization (see
“Experimental Procedures”).
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with an affinity (KD  160  8 nM) very similar to that of the
wild type E7Ep peptide (129 2 nM), whereas the FITC-labeled
P41A E7Ep and double mutant E7Ep peptides presented no
changes in anisotropy upon the addition of M1Fab up to the
micromolar concentration range (Fig. 8A). Based on the con-
centrations tested, we estimated that if an interaction occurred,
the KD values for the P41A and the double mutant peptides
were in the millimolar range or higher. Therefore, these exper-
iments allowed us to conclude that the Pro-41 residue was the
sole proline residue determining M1Fab affinity. We further
tested the association kinetics and found that the P47Amutant
also presented a monoexponential slow association phase, as
observed for the wild type E7Ep peptide (supplemental Fig. S5).
This observed phase became slower at increasing M1Fab con-
centrations (Fig. 8B). The average anisotropy value extrapo-
lated to t 0 was r 0.040 (supplemental Table S6), and con-
sidering the average anisotropy value of the free P47A E7Ep
fragment (r  0.032; supplemental Table S6), we obtained a
change in anisotropy of r 0.008 for the bimolecular associ-
ation reaction, in remarkable agreement with the parameters of
FIGURE 8. Equilibrium binding and association kinetics of the complex of E7Ep proline mutants with M1Fab. A, FITC fluorescence anisotropy change
measured upon adding increasing amounts of M1Fab to a cuvette containing 100 nM FITC- P47A E7Ep (filled circles), 100 nM FITC- P41A E7Ep (open circles), or
100 nM FITC- P41A	 P47A E7Ep (open triangles). The differentM1Fabantigen complexes were incubated in separate tubes for 30min prior tomeasurements.
The line is a fit of the data for the FITC-P47A E7EpM1Fab complex to a 1:1 binding model, from which the following dissociation constant was obtained (see
“Experimental Procedures”): KD 160 8 nM. The P41A E7Ep and the P41A/P47A E7Epmutants did not bind to theM1Fab at the concentrations tested, which
prevented fittingof thedata.B, concentrationdependenceof the slowassociationphase for theFITC-P47AE7EpM1Fabcomplexmeasuredat 50nMP47AE7Ep
andat increasingM1Fab concentrations. Theobserved rate constantswere obtained frommonoexponential fittingof the kinetic traces (supplemental Fig. S6),
and the line represents the fitting of the data to a pre-equilibriummodel by using Equation 4.
TABLE 1
Comparison between the slow association phase for E7Ep M1Fab binding and prolyl isomerization in free E7Ep
# Amplitudes and kinetic rate constants from association experiments were obtained from measurements performed at 20 °C (supplemental Tables S1 and S2).
* Isomer populations and kinetic rate constants from NMR experiments were extrapolated to 20 °C from the measured data at 30 and 40 °C (supplemental Table S5).
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the wild type E7Ep peptide (supplemental Table S1). The rela-
tive amplitude of the slow and fast association phases at 1 M
M1Fab were 87 and 13% respectively, also in excellent agree-
ment with the values obtained for wild type E7Ep (supplemen-
tal Tables S1 and S6). A fit of these data to the pre-equilibrium
model yielded values similar to those of the wild type peptide
(k1 3.2 0.3
 103 s1, k1 0.02 0.2 102 s1, andK
117 31 nM). These experiments confirmed that the slow asso-
ciation phase corresponded to the trans-cis isomerization of
proline residue 41 in E7Ep and that this residue also was
required for interaction with M1Fab.
AssociationKinetics of the E7EpM1FabComplex Followed by
Circular Dichroism—In order to determine whether M1-E7
binding was accompanied by changes in secondary structure,
we carried out circular dichroism (CD) experiments. As
expected, the E7Ep fragment had a CD spectrum characteristic
of a disordered polypeptidewith aminimumat 200 nm (Fig. 9A,
dotted line), whereas the M1Fab CD spectrum showed a high
content of 	-sheet structure, characteristic of Fabs (50) (Fig.
9A, solid line). A comparison of the spectrum of the
E7EpM1Fab complex (Fig. 9B, dashed line) with that obtained
by the sum of the individual spectra (Fig. 9B, solid line) showed
significant differences at 230, 216, and 203 nm, indicating that
structural changes had occurred upon binding.
Next, we performed kinetic experiments to monitor struc-
tural changes upon E7EpM1Fab binding. In these experiments,
the far-UVCD signal was recorded after the E7Ep fragmentwas
added to a cuvette containing M1Fab by manual mixing. We
chose to monitor structural changes at 203 nm, because it was
the wavelength at which the largest changes in the CD signal
took place. The bimolecular association phase is expected to be
fast at the micromolar concentrations used in these experi-
ments (5 M) and completed within the dead time of the man-
ual mixing (20 s). Interestingly, the time course of the reac-
tion showed two phases with opposite amplitudes, with rates
kobs1 6.5 0.4
 103 s1 for the phase with positive ampli-
tude and kobs2 5.1 0.8
 103 s1 for the phase with neg-
ative amplitude (Fig. 9C). Both rate constants and their net rate
(2.9 
 103 s1) were in agreement with the limiting value of
kobs  3 
 103 s1 expected for the pre-equilibrium isomer-
ization phase at high protein concentration (the end point from
the fit of the pre-equilibrium model; Fig. 4C). This result sug-
gested that one of the phases in the circular dichroism experi-
ments corresponded to the preassociation isomerization equi-
librium of Pro-41 in E7Ep and that this reaction was
accompanied by changes in secondary structure. The remain-
ing circular dichroism phase could correspond to a trans-cis
isomerization of Pro-47 in E7Ep that does not affect the inter-
action affinity or to an additional conformational rearrange-
ment in E7Ep or M1Fab.
DISCUSSION
Some antibodyantigen recognition events involve additional
species to the bound and unbound states, as is the case for the
association between E7 and the M1 antibody studied here. We
have determined rate constants for association, dissociation,
and first-order conformational rearrangements occurring
before and after the binding event, by means of kinetic and
equilibrium studies followed by fluorescence spectroscopy, cir-
cular dichroism, and nuclear magnetic resonance. With these
data, we propose a minimal kinetic model for the reaction
(Scheme 1).
The dissociation constant for the complex between full-
length E7 and M1Fab was in the nanomolar range, implying
that M1 had underwent affinity maturation close to the affinity
ceiling for antibodies (51) (Scheme 1 and Fig. 2). Kinetic analy-
ses yielded a rate constant for association of E7Ep with M1Fab
that approaches 6
 107 s1 M1 (Scheme 1 and Fig. 4), among
the fastest determined rates for antibodyantigen complexes
(52). In immunological terms, fast binding of the antigen may
be at least as important as high affinity, a phenomenon that has
been referred to as kinetic maturation (46).
The mechanism of biomolecular recognition is often dis-
cussed in terms of conformational selection versus induced fit
(53). In other words, either binding takes place only for a sub-
population of the unbound species or the twomolecules form a
complex that later rearranges. Our results suggest that both
phenomena play a role in M1-E7 complex formation. On one
hand, fluorescence anisotropy experiments revealed a slow
association phase, with a rate constant that decreased with
increasingM1Fab concentration (Fig. 4). This was indicative of
a conformational change in the free reactants, prior to binding
(8, 47) (Scheme 1). Thus, M1Ab-E7Ep recognition involves a
conformational selection step. On the other hand, the compar-
ison between kinetic and equilibrium constants indicated the
presence of a third step in the binding reaction involving a first-
FIGURE 9.Conformational changes associatedwith formation of the E7EpM1Fab complex. A, far-UV CD spectrumof 5MM1Fab (continuous line) and of
5ME7Ep (dotted line).B, CD spectrumof a stoichiometric 5ME7EpM1Fabcomplex incubated for 30minprior tomeasurement (dashed line) andCDspectrum
resulting from the sum of the individual E7Ep and M1Fab spectra (solid line). C, pre-steady-state change in ellipticity upon formation of the E7EpM1Fab
complex. The ellipticity change was measured at 203 nm after mixing 5 M M1 with 5 M E7Ep peptide. The time trace shows two phases with amplitudes of
different sign, which were fitted independently to single exponential functions to give the observed rate constants for each phase (kobs1 6.5 0.4
 10
3
s1 and kobs2 5.06 0.8
 10
3 s1).
Antibody Recognition of an Intrinsically Disordered Epitope
13120 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 288•NUMBER 18•MAY 3, 2013
 at M
A
RA
N
I on N
ovem
ber 20, 2013
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
order rearrangement of the complex that takes place after the
initial association event and has an estimated equilibrium con-
stant of about 6 (Scheme 1). This could be related to an induced
fit step. Moreover, the values of the two phases observed in the
dissociation reaction measured by both FITC fluorescence
intensity and anisotropy (Fig. 3) were in agreement with this
hypothesis. Additional interrupted binding (double-jump)
experiments (54) are required to better define this induced fit
step of the recognition mechanism.
The presence of two proline residues in the E7 epitope
prompted us to assess whether the conformational selection
event could be related to prolyl isomerization. NMR experi-
ments revealed that both proline residues within E7Ep pre-
sented an isomerization equilibrium with a predominance of
the trans over the cis isomer (Figs. 6 and 7), as expected for an
intrinsically disordered peptide. The equilibrium and kinetic
properties of the proline isomerization reactions in unbound
E7Ep by NMR are in remarkable agreement with the corre-
sponding parameters of the preassociation equilibrium (Figs.
5–7 and Table 1), which allowed us to assign the conforma-
tional selection event to a proline isomerization in E7Ep. The
reaction parameters for isomerization of Pro-41 and Pro-47 are
very similar and did not allow discrimination of the Pro residue
involved. However, mutagenesis experiments clearly indicated
that Pro-41 was necessary, whereas Pro-47 was dispensable for
binding (Fig. 8). We determined that the M1 antibody binds to
the cis isomer of the antigen, which is populated to about 10%
(Scheme 1 and Table 1) and that the kinetics of the selection
step is limited by the rate constant for trans to cis isomerization,
which involves a conformational rearrangement in E7Ep.
We have narrowed down the E7 epitope to the intrinsically
disordered E7Ep fragment (E7(36–48)) using ELISA and fluo-
rescence anisotropy (Figs. 1 and 2). Interestingly, E7Ep contains
the immunodominant B epitope, which was also targeted by
antiproliferative single chain antibodies (55). Of the three main
immunodominant epitopes of E7 (36, 37), two are located in the
same region and contained within E7Ep. Peptide epitopes are
often found in protein regions with residual conformations or
conformational ensembles (14). The E7 epitope spans a region
of E7 that indeed appears as disordered by NMR, crystallogra-
phy, and circular dichroism spectroscopy (56, 57) (Fig. 9). It has
been proposed that structural transitions within disordered
regions could increase immunogenicity (58). Our data show
that trans to cis isomerization of Pro-41 is a requirement for
E7EpM1Fab complex formation (Scheme 1). It is plausible that
presentation of a “locked” cis conformation by the antigen-pre-
senting cells may enhance epitope immunogenicity.
The intrinsically disordered E7N domain can be described as
a succession of conserved linear motifs that bind cellular tar-
gets, separated by linkers of variable sequence and length (59).
TheM1 E7Ep epitope is located in the last of the linkers in E7N,
which joins the E7N CR2 region with the globular E7C domain
and lacks known binding sites. The proline residues within
E7Ep are conserved among HPV E7 proteins from the 9 spe-
cies (Fig. 5B), but this region is highly divergent across E7 pro-
teins fromotherHPV species (59). This may explain whyM1 is
able to discriminate the HPV16 E7 protein from the HPV18
E7 protein, which belongs to the closely related 7 species
(supplemental Fig. S1). This ability of M1 to distinguish the E7
proteins from the two main high risk HPV types may prove
useful for diagnostic applications.
We have recently described the kinetic interaction mecha-
nism of the LXCXE linear motif within the E7N CR2 region
with the retinoblastoma tumor suppressor RbAB domain (42).
The LXCXE-RbAB interaction is a fast two-state process, indi-
cating that sampling of the conformational ensemble in this
region of the E7N domain is very fast. In contrast, the kinetic
interaction mechanism of the E7Ep epitope with the M1 anti-
body displays a slow conformational selection step limited by
prolyl isomerization. Because linear motifs are often rich in
proline residues (60), this result suggests that linear motif rec-
ognitionmay be limited by proline isomerization in other cases.
Proline isomerization within E7Ep may be coupled not only to
antibody binding but also to rearrangement of the relative posi-
tions of the E7N and E7C domains. This could play an impor-
tant role in the caseswhere the twoE7domains cooperate in the
binding of cellular targets, such as binding of the retinoblas-
toma protein (42). The other linker regions in E7N are also rich
in proline residues (59), suggesting that the isomerization of
specific peptide bonds may govern other slow conformational
transitions and recognition events in many E7 proteins. A pic-
ture emerges where different regions of the disordered E7N
domain can present conformational equilibria on different time
scales. This allows for a diversity of interaction mechanisms,
which are a salient feature of intrinsically disordered domains
and include both pre- and postbinding rearrangement events
(61–63) as well as the existence of a variety of conformational
states in the ligand-bound form (64).
We have investigated the recognition of an HPV E7 epitope,
which was also found to be the main immunodominant B cell
epitope in humans (65). In addition to its interest for diagnostic
applications, the immune response toward this oncoprotein is
the basis of therapeutic vaccines against HPV cancer under
development (25, 66). We revealed a peptide epitope with two
proline isomers that may constitute discrete structural states
and interconvert in theminute time scale. Antibody isomeriza-
tion extends the immune repertoire by allowing binding of
more than one antigen by a single antibody primary sequence.
In a similar way, proline isomerization may provide with alter-
native conformations that regulate binding to different anti-
bodies or protein ligands. Further structural and thermody-
namic studies will be required to completely dissect this
interaction mechanism. It will be interesting to investigate
whether there is a common theme in the rules governing the
recognition of intrinsically disordered viral epitopes, such as
those found in E7, by the immune system, because the IDP
nature is abundantly represented among multifunctional viral
proteins.
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